Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment-Experienced Patients”

366 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 366 results

Testing effectiveness (Phase 2)Study completedNCT00943540
What this trial is testing

Pharmacokinetic and Safety Study of Raltegravir and Atazanavir in a Once Daily Dose Regimen in HIV-1 Infected Patients

Who this might be right for
HIV InfectionHIV Infections
Radboud University Medical Center 20
Not applicableStudy completedNCT00665561
What this trial is testing

Prospective Observational Epidemiologic Study of Maraviroc's Safety

Who this might be right for
Human Immunodeficiency Virus
ViiV Healthcare 2,500
Early research (Phase 1)Study completedNCT00006509
What this trial is testing

The Safety and Effectiveness of an HIV Vaccine for HIV-Positive Patients Receiving Anti-HIV Drugs for at Least 2 Years

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 12
Not applicableStudy completedNCT00046267
What this trial is testing

Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected Patients

Who this might be right for
HIV InfectionsHypercholesterolemiaHypertriglyceridemia+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 30
Early research (Phase 1)Study completedNCT00129194
What this trial is testing

Study of KP-1461 for the Treatment of HIV Positive Patients Who Have Failed Multiple HAART Regimens

Who this might be right for
HIV Infections
Koronis Pharmaceuticals. 40
Testing effectiveness (Phase 2)Ended earlyNCT00385567
What this trial is testing

A Trial of PEHRG214 in HIV-Infected Patients

Who this might be right for
HIV Infections
Virionyx Corporation Limited 70
Testing effectiveness (Phase 2)Ended earlyNCT00294372
What this trial is testing

Phase II Study on the Antiviral Activity and Safety of BILR 355 BS in HIV-1 Infected, NNRTI-treated Patients

Who this might be right for
HIV Infections
Boehringer Ingelheim 36
Testing effectiveness (Phase 2)Study completedNCT00126880
What this trial is testing

AVX754 (a New Nucleoside Reverse Transcriptase Inhibitor [NRTI]) to Treat Drug-resistant HIV

Who this might be right for
HIV Infections
Avexa 52
Early research (Phase 1)Ended earlyNCT00757250
What this trial is testing

Safety Study of TXA127 to Elevate CD4+ T-Lymphocyte Counts in HIV-Infected Patients on Stable HAART Therapy

Who this might be right for
HIV Infections
US Biotest, Inc. 13
Testing effectiveness (Phase 2)Ended earlyNCT02239835
What this trial is testing

Tipranavir and Ritonavir vs. Saquinavir and Ritonavir Used With Two Nucleoside Reverse Transcriptase Inhibitors in Single Protease Inhibitor-experienced HIV-1 Patients

Who this might be right for
HIV Infections
Boehringer Ingelheim 79
Not applicableStudy completedNCT00259389
What this trial is testing

Directly Observed Therapy for HIV Infected Adolescents

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Large-scale testing (Phase 3)Study completedNCT00524368
What this trial is testing

Compare Effectiveness and Safety of Darunavir/Ritonavir (DRV/Rtv) 800mg/100mg Once Daily Versus DRV/Rtv 600mg/100mg Twice Daily in Early Treatment-Experienced HIV-1 Infected Patients (ODIN)

Who this might be right for
Human Immunodeficiency Virus - Type 1
Tibotec Pharmaceuticals, Ireland 590
Post-approval studies (Phase 4)Study completedNCT03420300
What this trial is testing

EBR/GZR for HCV-1b Patients Receiving Hemodialysis

Who this might be right for
Hepatitis C
National Taiwan University Hospital 40
Early research (Phase 1)UnknownNCT04756934
What this trial is testing

HX008 Plus LP002 for the Treatment of Patients With Advanced Melanoma

Who this might be right for
Melanoma
Taizhou HoudeAoke Biomedical Co., Ltd. 63
Testing effectiveness (Phase 2)Ended earlyNCT05571267
What this trial is testing

Safety Study of Zimura in Combination With Anti-VEGF Therapy in Patients With Neovascular AMD

Who this might be right for
Neovascular Age-Related Macular Degeneration
IVERIC bio, Inc. 1
Post-approval studies (Phase 4)Study completedNCT02360592
What this trial is testing

Combination Therapy With Interferon Plus Interleukin 2 and Hepatitis B Vaccine in Chronic Hepatitis B Patients

Who this might be right for
Hepatitis B, Chronic
Tongji Hospital 94
Not applicableStudy completedNCT00979420
What this trial is testing

Non-interventional Observational Study With Viramune (Nevirapine) and Various Drug Combinations in the Antiretroviral Combination Treatment of HIV-infected Patients Who Have Already Been Treated for Approx. 10 Years With Viramune

Who this might be right for
HIV Infections
Boehringer Ingelheim
Not applicableStudy completedNCT04577482
What this trial is testing

Study of Oral Glecaprevir/Pibrentasvir Tablets in Participants Aged 12 Years or Older With Chronic Hepatitis C to Assess Sustained Virological Response

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 42
Large-scale testing (Phase 3)Study completedNCT02707861
What this trial is testing

Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1

Who this might be right for
HIV
TaiMed Biologics Inc. 79
Post-approval studies (Phase 4)Study completedNCT00447070
What this trial is testing

Effect of Atazanavir on Endothelial Function in HIV-Infected Patients

Who this might be right for
HIV InfectionsDyslipidemia
Foundation for Cardiovascular Research, Zurich 50
Next Page